KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maxlinear (MXL) EBT (2016 - 2025)

Maxlinear (MXL) has disclosed EBT for 16 consecutive years, with -$17.8 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 56.39% to -$17.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$140.9 million, a 40.98% increase, with the full-year FY2025 number at -$140.9 million, up 40.98% from a year prior.
  • EBT was -$17.8 million for Q4 2025 at Maxlinear, up from -$43.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $45.0 million in Q1 2022 to a low of -$82.5 million in Q3 2024.
  • A 5-year average of -$11.1 million and a median of -$12.5 million in 2021 define the central range for EBT.
  • Peak YoY movement for EBT: soared 703.12% in 2022, then crashed 768.19% in 2024.
  • Maxlinear's EBT stood at $28.5 million in 2021, then surged by 42.96% to $40.7 million in 2022, then crashed by 204.71% to -$42.6 million in 2023, then rose by 4.24% to -$40.8 million in 2024, then soared by 56.39% to -$17.8 million in 2025.
  • Per Business Quant, the three most recent readings for MXL's EBT are -$17.8 million (Q4 2025), -$43.4 million (Q3 2025), and -$30.7 million (Q2 2025).